Intech Biopharm Corporation (TPEX:6461)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.70
-1.20 (-5.02%)
Mar 4, 2026, 9:19 AM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Research and Development Technology and Drug Trading Business
39.78M25.85M23.65M38.90M21.11M
Research and Development Technology and Drug Trading Business Growth
53.90%9.30%-39.21%84.30%26.50%
Total
39.78M25.85M23.65M38.90M21.11M
Total Growth
53.90%9.30%-39.21%84.30%26.50%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Taiwan
36.18M21.85M10.61M10.34M14.30M
Taiwan Growth
65.54%105.91%2.66%-27.70%-6.23%
China
-1.12M9.32M28.23M5.81M
China Growth
--87.99%-66.98%386.07%414.44%
Hong Kong
1.83M1.75M919.00K--
Hong Kong Growth
4.98%89.99%---
Other
1.77M1.13M2.79M--
Other Growth
56.91%-59.60%---
Malaysia
---153.00K-
Costa Rica
---177.00K-
Cambodia
----999.00K
Cambodia Growth
----226.47%
Total
39.78M25.85M23.65M38.90M21.11M
Total Growth
53.90%9.30%-39.21%84.30%26.50%
Source: S&P Global Market Intelligence.